SUNESIS PHARMACEUTICALS, INC. (NASDAQ: SNSS) - $2.62.
Twelve-month hi-low has been $5.75 - $2.11. Located in South San Francisco, CA, with about 108 employees, this biotech has 34.3 million shares outstanding, $66.64 million in total current assets, $72 million in total assets, and $12.71 million in total liabilities, of which $1.3 million is long-term debt. Institutional ownership is around 78%.
Pretty good speculative buy at this price, IMO! Keep in mind that this is a listed-stock (not OTC) which makes it lower risk at losing money, and its not an overnight play but has been recommended by 4 analysts at these levels!
Market Data 
Markets 
AI
